<DOC>
	<DOCNO>NCT01770951</DOCNO>
	<brief_summary>The objective retrospective trial ass safety efficacy eculizumab aHUS patient treat outside Alexion-sponsored control clinical trial .</brief_summary>
	<brief_title>A Retrospective , Observational , Non-interventional Trial Assess Eculizumab Treatment Effect Patients With Atypical Hemolytic Uremic Syndrome ( aHUS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Azotemia</mesh_term>
	<mesh_term>Hemolytic-Uremic Syndrome</mesh_term>
	<mesh_term>Atypical Hemolytic Uremic Syndrome</mesh_term>
	<criteria>1 . Male female patient age diagnose aHUS . 2 . Received least one dose eculizumab treatment aHUS 2007 2009 outside Alexion sponsor control clinical trial . 1 . Patients participate currently participate control clinical trial eculizumab</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>